Dongwha Pharm.Co.Ltd Balance Sheet Health
Financial Health criteria checks 4/6
Dongwha Pharm.Co.Ltd has a total shareholder equity of ₩405.9B and total debt of ₩57.8B, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are ₩587.1B and ₩181.2B respectively. Dongwha Pharm.Co.Ltd's EBIT is ₩8.9B making its interest coverage ratio -5.7. It has cash and short-term investments of ₩40.1B.
Key information
14.2%
Debt to equity ratio
₩57.82b
Debt
Interest coverage ratio | -5.7x |
Cash | ₩40.09b |
Equity | ₩405.92b |
Total liabilities | ₩181.18b |
Total assets | ₩587.11b |
Recent financial health updates
These 4 Measures Indicate That Dongwha Pharm.Co.Ltd (KRX:000020) Is Using Debt Safely
Mar 11Is Dongwha Pharm.Co.Ltd (KRX:000020) Using Too Much Debt?
Dec 04Recent updates
Dongwha Pharm.Co.Ltd's (KRX:000020) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Nov 20Dongwha Pharm.Co.Ltd's (KRX:000020) Promising Earnings May Rest On Soft Foundations
Mar 26Is Dongwha Pharm.Co.,Ltd (KRX:000020) A Smart Pick For Income Investors?
Apr 28These 4 Measures Indicate That Dongwha Pharm.Co.Ltd (KRX:000020) Is Using Debt Safely
Mar 11Dongwha Pharm.Co.,Ltd (KRX:000020) Has A ROE Of 8.6%
Feb 22Is Dongwha Pharm.Co.Ltd's (KRX:000020) Share Price Gain Of 102% Well Earned?
Feb 07Should Dongwha Pharm.Co.,Ltd (KRX:000020) Be Part Of Your Dividend Portfolio?
Jan 23Is Dongwha Pharm.Co.,Ltd (KRX:000020) Popular Amongst Insiders?
Jan 08Dongwha Pharm.Co.,Ltd (KRX:000020) Pays A ₩120 Dividend In Just Four Days
Dec 24We're Not Counting On Dongwha Pharm.Co.Ltd (KRX:000020) To Sustain Its Statutory Profitability
Dec 19Is Dongwha Pharm.Co.Ltd (KRX:000020) Using Too Much Debt?
Dec 04Can Dongwha Pharm.Co.,Ltd (KRX:000020) Improve Its Returns?
Nov 19Financial Position Analysis
Short Term Liabilities: A000020's short term assets (₩218.2B) exceed its short term liabilities (₩108.2B).
Long Term Liabilities: A000020's short term assets (₩218.2B) exceed its long term liabilities (₩73.0B).
Debt to Equity History and Analysis
Debt Level: A000020's net debt to equity ratio (4.4%) is considered satisfactory.
Reducing Debt: A000020's debt to equity ratio has increased from 0% to 14.2% over the past 5 years.
Debt Coverage: A000020's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A000020 earns more interest than it pays, so coverage of interest payments is not a concern.